Progress in Mind
Skizofreni
Video
Vælg et område
Check de forskellige Progress in Mind indholdsområder.
Skizofreni
Video
Video #6: Which patients are best suited for long-acting injectable antipsychotics?
Depression
Satellite symposium
Treatment outcomes that matter – established and emerging therapies for patients with major depressive disorder who do not respond adequately to antidepressants
Major depressive disorder (MDD) has significant costs to society and is predicted to be the leading...
Depression
Congress highlights
Can inflammatory biomarkers help to personalize depression treatment?
Which treatment is best suited for which type of depression? Patients with a subtype of major...
Skizofreni
Video
Video #7: Long-acting injectable antipsychotics in the treatment plan of patients with schizophrenia
Skizofreni
Satellite symposium
Treatment outcomes in schizophrenia – what matters to patients?
Schizophrenia treatment has moved from mainly addressing relapse prevention and symptom suppression...
Depression
Satellite symposium
Targeting what matters most for patients with depression: Strategies for promoting full functional recovery
Major depression is a common and serious condition with symptoms across domains and being very...
Depression
Congress highlights
Immune modulation in psychiatric disorders: Are we there yet?
It has been argued that drug discovery for psychiatric disorders is at a near standstill. Which...
Skizofreni
Video
What do clinical goals mean to patients with schizophrenia?
Skizofreni
Video
Video #4: Discussing the benefit of long-acting injectable antipsychotics with patients and carers
Depression
Satellite symposium
Emotional blunting: unresolved MDD symptom or effect of treatment?
Some evidence suggests that emotional blunting is a side effect of therapy, but other evidence...
Mental health
Congress highlights
What is the role of inflammation in the pathophysiology of mood disorders?
Evidence supporting a role for inflammation and pro-inflammatory mediators in the pathophysiology...